中红外 germanium-on-silicon 波导传感器用于抗癫痫药物苯巴比妥的治疗药物监测
Mid-infrared germanium-on-silicon waveguide sensor for therapeutic drug monitoring of phenytoin
AI总结:
中红外 germanium-on-silicon 波导传感器用于快速检测苯巴比妥血清浓度,实现治疗药物监测的高灵敏度和宽动态范围。
摘要:
我们报告了中红外 germanium-on-silicon 波导传感器的设计、制造和表征,用于治疗药物监测(TDM)。TDM 需要快速准确地测定血清药物浓度,但现有的临床检测依赖于实验室仪器,限制了床边应用。在本研究中,可调谐二极管激光吸收光谱法被用于分析抗癫痫药物苯巴比妥在 λ = 5.6 - 6.0 μm 光谱区域的干燥样本。提取样本的检测限为 2.20 mg/L,其中苯巴比妥首先被加入到人类血清中,随后通过液-液萃取进行分离。此检测限显著低于苯巴比妥的治疗窗口(10 - 20 mg/L),能够检测到亚治疗浓度。同时,传感器在 40 mg/L 以内保持一致的剂量依赖性响应,证明了其能够定量测定治疗窗口和上限以上的浓度。这验证了硅光子学在生物红外光谱学中用于接受药物治疗的患者中的应用潜力,无论血清药物浓度是过高还是过低。这些结果突显了中红外集成光子学在构建紧凑、可扩展的床边 TDM 平台中的潜力。
英文摘要:
We report the design, fabrication and characterization of evanescent mid-infrared germanium-on-silicon waveguide sensors for therapeutic drug monitoring (TDM). TDM requires rapid and accurate quantification of serum drug levels but existing clinical assays rely on laboratory-based instrumentation that limits point-of-care deployment. In this work, tunable diode laser absorption spectroscopy was used to analyze dried samples of the anti-seizure medication phenytoin in the spectral region of $λ$ = 5.6 - 6.0 $μ$m. A limit of detection of 2.20 mg/L was achieved for extracted samples, where phenytoin was first added to human serum and subsequently isolated using liquid-liquid extraction. This limit is significantly below the therapeutic window of 10 - 20 mg/L for phenytoin, enabling detection of sub-therapeutic concentrations. At the same time, the sensor maintains a consistent dose-dependent response up to 40 mg/L, demonstrating its capability to quantify concentrations across the therapeutic window and above the upper therapeutic limit. This validates the use of silicon photonics for biomedical infrared spectroscopy for patients undergoing drug therapy, whether the serum-drug concentration is either too high or too low. These results highlight the potential of mid-IR integrated photonics to form the basis of compact, scalable platforms for point-of-care TDM.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。